Lactobacillus plantarum YM-4-3 and application thereof
By isolating and identifying Lactobacillus plantarum YM-4-3 in De traditional anaerobic fermented fermented black beans in Yimen County, Yuxi City, Yunnan Province, the problem of improving constipation in the existing technology is solved, and the survival of this strain in the gastrointestinal tract is achieved. and pathogenic bacteria inhibition demonstrate its application potential in constipation and antioxidant products.
Patent Information
- Application Number
- CN202411290520.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-02-03
- Filing Date
- 2024-09-14
- Publication Date
- 2024-11-29
AI Technical Summary
The prior art is difficult to effectively improve constipation, and the application of probiotics has not been fully developed.
Isolated and identified a kind of Lactobacillus plantarum YM-4-3. It is a traditional anaerobic fermented fermented black beans from Yimen County, Yuxi City, Yunnan Province. It has excellent acid resistance, bile salt resistance and gastrointestinal adhesion ability, which can significantly inhibit the development of the disease. germs and are used to prepare constipation-improving and antioxidant products.
Lactobacillus plantarum YM-4-3 significantly improves constipation, has high DPPH and ABTS free radical clearance, can survive in the gastrointestinal environment and inhibit pathogenic bacteria, used to prepare products that prevent or improve constipation and antioxidant, showing Excellent biological activity and safety.
Smart Images

Figure CN119040200A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of microorganisms, and in particular to a plant lactobacillus capable of improving constipation and application thereof. Background Art
[0002] Constipation is a complex disease caused by abnormal large intestine motility. The prevalence of constipation has increased significantly compared with previous years, up to one-third. Studies have shown that probiotics can help improve constipation. And compared with laxatives, probiotics have very few side effects. Probiotics promote the growth and colonization of beneficial bacteria in the body by lowering the pH value of the body's microenvironment, and adhere to the intestinal mucosa to compete with pathogens for colonization sites, causing pathogens to be inhibited to a certain extent, thereby achieving its function of regulating intestinal flora. Therefore, screening out probiotics that can effectively improve constipation has broad market prospects and value. Summary of the invention
[0003] The technical problem to be solved by the present invention is to provide a strain of Lactobacillus plantarum that can effectively improve constipation.
[0004] The invention provides a lactobacillus plantarum YM-4-3. The lactobacillus plantarum YM-4-3 (Lactobacillus plantarum YM-4-3) has been deposited in China Center for Type Culture Collection on March 6, 2023, with a deposit number of CCTCC NO: M2023253.
[0005] The invention provides a bacterial agent comprising Lactobacillus plantarum YM-4-3.
[0006] The invention provides a fermentation product obtained by fermenting Lactobacillus plantarum YM-4-3 or a bacterial agent.
[0007] The invention provides an application of plant lactobacillus YM-4-3 or a bacterial agent or a fermentation product in preparing a product for preventing or improving constipation.
[0008] The product is food or health product.
[0009] The invention provides application of plant lactobacillus YM-4-3 or a bacterial agent or a fermentation product in preparing an antioxidant product.
[0010] The product is food or health product.
[0011] Beneficial effects of the present invention:
[0012] The plant lactobacillus YM-4-3 isolated from traditional anaerobic fermented fermented black beans in Yimen County, Yuxi City, Yunnan Province can effectively improve constipation, has excellent DPPH free radical scavenging rate and ABTS free radical scavenging rate, and has good acid resistance, bile salt resistance and gastrointestinal adhesion ability, has a high survival rate in the gastrointestinal environment, can significantly inhibit the reproduction of gastrointestinal pathogens, especially Staphylococcus aureus and Salmonella typhimurium, and can be used to prepare products for preventing or improving constipation, as well as antioxidant products. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] Figure 1 is the colony morphology of Lactobacillus plantarum YM-4-3;
[0014] Figure 2 This is a diagram showing some of the different metabolites between fermented soy milk and unfermented soy milk obtained by fermentation with Lactobacillus plantarum YM-4-3;
[0015] Figure 3 This is a display diagram of some of the most significantly up-regulated and down-regulated metabolites among the differential metabolites;
[0016] Figure 4 This is the result of drug sensitivity test culture. DETAILED DESCRIPTION
[0017] The specific embodiments of the present invention are further described below in conjunction with the accompanying drawings. It should be noted that the description of these embodiments is used to help understand the present invention, but does not constitute a limitation of the present invention. In addition, the technical features involved in the various embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.
[0018] The invention provides a strain of Lactobacillus plantarum YM-4-3, which is separated from traditional anaerobic fermented fermented black beans in Yimen County, Yuxi City, Yunnan Province. Lactobacillus plantarum YM-4-3 (Lactobacillus plantarum YM-4-3) has been deposited in China Center for Type Culture Collection on March 6, 2023, with a deposit number of CCTCC NO: M2023253; the deposit address is: Luojia Mountain, Bayi Road, Wuchang District, Wuhan City, Hubei Province; Contact number: 027-68754052.
[0019] The invention provides a bacterial agent comprising plant lactobacillus YM-4-3 and other auxiliary materials.
[0020] The invention provides a fermentation product obtained by fermenting Lactobacillus plantarum YM-4-3 or a bacterial agent.
[0021] The present invention provides an application of plant lactobacillus YM-4-3 or a bacterial agent or a fermentation product in preparing a product for preventing or improving constipation. The product is a food or a health product.
[0022] The invention provides application of plant lactobacillus YM-4-3 or a bacterial agent or a fermentation product in preparing an antioxidant product.
[0023] The product is food or health product.
[0024] The following is a detailed description of a strain of Lactobacillus plantarum YM-4-3 and its application provided by the present invention in conjunction with the embodiments, but they should not be construed as limiting the scope of protection of the present invention.
[0025] Example 1
[0026] Isolation, purification, identification and storage of Lactobacillus plantarum YM-4-3
[0027] 1. Isolation and Purification of Strains
[0028] Lactobacillus plantarum YM-4-3 was isolated from traditional anaerobic fermented fermented black beans in Yimen County, Yuxi City, Yunnan Province. The method is as follows: 100g of traditional anaerobic fermented black beans sample from Yimen County, Yuxi City, Yunnan Province was taken for use. 1.0g of the black bean sample was weighed and placed in 10mL of sterile saline. After fully eluting the attached microorganisms, the sample was ground and inoculated into 5mL of MRS broth medium, and anaerobically cultured at 37°C for 24h; then gradient dilution was performed with sterile saline, and the dilution was spread on MRS agar medium and placed at 37°C for anaerobic culture for 48 to 72h. After a single colony was grown, the single colony was repeatedly streaked on MRS agar medium for strain separation and purification. Single colonies were selected according to the different morphological characteristics of the colony, such as morphology, color, size, whether it was raised, transparency, and whether the edge was regular. A single colony was inoculated into 5 mL of sterilized MRS broth medium, cultured at 37°C for 48 h, and then stored in a -80°C refrigerator with 50% glycerol for later use.
[0029] The MRS broth medium formula is: 10g protein Chen, 8g beef powder, 4g yeast powder, 20g glucose, 1mL Tween 80, 2g dipotassium hydrogen phosphate, 5g sodium acetate, 2g triammonium citrate, 0.2g magnesium sulfate, 0.05g manganese sulfate, 1L distilled water, pH 6.2±0.2.
[0030] 2. Morphological identification of strains
[0031] The isolated plant lactobacillus YM-4-3 strain was subjected to Gram staining, microscopic identification and catalase test. The results showed that the strain was a short rod with Gram staining positive bacteria and a negative catalase test; the colonies on the MRS agar plate were milky white, smooth, with obvious protrusions, neat edges, opaque and shiny. The colony morphology of plant lactobacillus YM-4-3 is shown in the figure below. Figure 1 shown.
[0032] 3. Molecular Biological Identification of Strain
[0033] The isolated and purified single colony was sent to Bioengineering (Shanghai) Co., Ltd., and the identification primers were: 27F: 5'-AGAGTTTGATCMTGGCTCAG-3'; 1492R: 5'-GGTTACCTTGTTACGACTT-3'. The BLAST program in NCBI was used to compare and analyze the measured sequences. The results showed that the YM-4-3 strain was Lactobacillus plantarum among lactic acid bacteria, and its homology with the known Lactobacillus plantarum in the Gene Bank database reached 99.95%, and was named Lactobacillus plantarum (Lactobacillus plantarum YM-4-3).
[0034] 4. Strain preservation
[0035] Lactobacillus plantarum YM-4-3 (Lactobacillus plantarum YM-4-3) was deposited in the China Center for Type Culture Collection on March 6, 2023, with the address: Luojia Mountain, Bayi Road, Wuchang District, Wuhan City, Hubei Province, with the deposit number CCTCCNO: M2023253, telephone: 027-68754052.
[0036] Example 2
[0037] Analysis of acid and bile resistance of Lactobacillus plantarum
[0038] 1. Acid resistance test
[0039] Use MRS broth medium to activate and culture Lactobacillus plantarum YM-4-3. After culturing at 37°C for 24 hours, take 1 mL of bacterial solution in a 1.5 mL sterile centrifuge tube. Treat with MRS broth medium with a pH of 3.0. Repeat 3 times for each sample, and take 1 mL of bacterial solution at 0h and 3h respectively. After diluting to a certain concentration, use the live bacteria plate count method to determine the number of live bacteria: evenly spread the diluted sample on the sterilized and cooled MRS agar plate, and determine the number of live bacteria after culturing at 37°C for 24 hours. The live bacteria value on each plate is between 20-200 for validity. The formula for calculating the survival rate of the strain is as follows:
[0040]
[0041] Wherein, N1 is the number of viable bacteria after 3 h of culture in a medium with a pH of 3.0; N0 is the initial number of viable bacteria of the strain.
[0042] The calculation results showed that the survival rate of Lactobacillus plantarum YM-4-3 after being treated with acid at pH 3.0 for 3 hours was 90.5%.
[0043] 2. Bile salt tolerance test
[0044] Use MRS broth medium to activate and culture Lactobacillus plantarum YM-4-3. After culturing at 37°C for 24 hours, take 1 mL of the bacterial solution in a 1.5 mL sterile centrifuge tube. Treat with 0.3% pig bile salt. Repeat 3 times for each sample, and take 1 mL of the bacterial solution at 0h and 3h of culture. After diluting to a certain concentration, use the live bacteria plate count method to determine the number of live bacteria: evenly spread the diluted sample on the sterilized and cooled MRS agar plate, and count the number of live bacteria after culturing at 37°C for 24 hours. The live bacteria value on each plate is between 20-200 for validity. The formula for calculating the survival rate of the strain is as follows:
[0045]
[0046] Where N1 is the number of viable bacteria of YM-4-3 strain after being cultured in medium containing bile salts for 3 hours; N0 is the initial number of viable bacteria of YM-4-3 strain.
[0047] The calculation results show that the survival rate of Lactobacillus plantarum YM-4-3 after being treated with 0.3% concentration of pig bile salt medium is 85%. The experimental results show that Lactobacillus plantarum YM-4-3 has strong acid and bile salt resistance.
[0048] Example 3
[0049] Simulated artificial gastrointestinal fluid tolerance test
[0050] Preparation of artificial gastric juice: NaCl 0.2g / 100mL, pepsin 0.35g / 100mL, adjust the pH to 2.0, 2.5, 3.0, 4.0 with 1mol / L HCl, filter and sterilize (0.22um membrane) for use, and prepare artificial gastric juice with different pH values.
[0051] Preparation of artificial intestinal fluid: NaHCO3 1.1g / 100mL, NaCl 0.2g / 100mL, trypsin 0.1g / 100mL, pig bile salt 1.8g / 100mL, adjust the pH value to 8.0, filter and sterilize for later use, and prepare artificial intestinal fluid.
[0052] Take 0.5mL of the test bacterial solution and add it to 4.5mL of artificial gastric fluid, shake it for 10s, and then place it in 37℃ anaerobic culture. Take samples at 0h, 1h, 2h, and 3h of treatment to measure the number of viable bacteria. Then take 0.5mL of the above 3h artificial gastric fluid reaction solution and add it to 4.5mL of artificial intestinal fluid, shake it for 10s, and then place it in 37℃ anaerobic culture. Take samples at 0h, 3h, 8h, and 24h of treatment to measure the number of viable bacteria.
[0053]
[0054] N0: number of viable bacteria before treatment;
[0055] N1: The number of viable bacteria treated with artificial gastric juice or artificial gastrointestinal juice.
[0056] The statistical test data are described in the following table:
[0057]
[0058]
[0059] From the above results, it can be seen that at the end of the gastrointestinal fluid transport experiment at pH 4.0 and 3.0, the activity rate of Lactobacillus plantarum YM-4-3 was higher than 90%; after treatment with gastric juice at pH 2.5 for 3 hours, the survival rate was 86.41%, and after treatment with intestinal juice at pH 2.5 for 24 hours, the survival rate was 74.14%; after treatment with gastric juice at pH 2.0 for 3 hours, the survival rate was 37.03%, and after treatment with intestinal juice at pH 2.0 for 8 hours, the survival rate was 91.56%.
[0060] This indicates that Lactobacillus plantarum YM-4-3 can tolerate gastrointestinal fluids at pH 4.0 and 3.0, and has a certain tolerance to gastrointestinal fluid transport at pH 2.5. The pH of the stomach of a normal human body is maintained between 3.0 and 5.0 after eating. Therefore, Lactobacillus plantarum YM-4-3 can survive in the human gastrointestinal tract.
[0061] Example 4
[0062] Adhesion rate test of Lactobacillus plantarum YM-4-3 to intestinal epithelial cells
[0063] The test steps are as follows:
[0064] (1) Lactobacillus plantarum YM-4-3 was inoculated into 200 ml of liquid culture medium at a 1% inoculum concentration and cultured at 37°C for 48 h. The bacterial suspension was adjusted to 10 7 cfu / mL, set aside.
[0065] (2) HT-29 cells were cultured in DMEM medium in a 5% CO2 incubator at 37°C overnight. The medium was replaced on the next day. When the cell proliferation rate reached about 80%, the cells were digested with 0.2% trypsin. The cells were passaged at a ratio of 1:3, and logarithmically growing cells were used for the experiment.
[0066] (3) Co-culture of HT-29 cells with probiotic strains: The cultured HT-29 cells were transferred to a 6-well plate for overnight culture, the cultured Lactobacillus plantarum YM-4-3 was rinsed with PBS and resuspended in DMEM medium, and the resuspension was added to the HT-29 cell plate in the same volume and cultured for 3 hours. After rinsing the cells with PBS, they were fixed with methanol for 30 minutes and observed by Gram staining.
[0067] Statistics show that the adhesion rate of YM-4-3 on HT-29 cells is 79%, indicating that Lactobacillus plantarum YM-4-3 has a strong ability in cell colonization.
[0068] Example 5
[0069] Antibacterial test
[0070] ① Experimental materials
[0071] The above-screened probiotic strains YM-4-3, foodborne Escherichia coli O157:H7, Salmonella typhimurium, Staphylococcus aureus, and Listeria monocytogenes were stored in the Applied Microbiology Laboratory of the School of Life Sciences and Technology, Kunming University of Science and Technology.
[0072] Culture medium
[0073] MRS agar medium;
[0074] LB medium: peptone 10.0 g, yeast powder 5.0 g, sodium chloride 5.0 g, glucose 1.0 g, adjust pH to 7.1 ± 0.1 (25 °C), add distilled water to 1 L, sterilize at 121 °C for 15 min;
[0075] BHI medium: peptone 10.0 g, beef extract powder 3.0 g, sodium chloride 5.0 g, glucose 1.0 g, adjust the pH to 7.4±0.1 (25°C), add distilled water to 1 L, and sterilize at 121°C for 15 min.
[0076] ②Test methods
[0077] The antibacterial ability of the strain was determined using the agar well diffusion method. The specific method was as follows: first, a thin layer of MRS agar medium was poured into the plate, and after solidification, an Oxford cup was placed in it. Then, a second layer of MRS agar medium was poured in, and after solidification, the Oxford cup was removed. 100 μL of 10% agar medium that had been activated in advance was added to the well. 9 cfu / mL of YM-4-3 was placed in an incubator at 37°C for 24 h, and then the foodborne Escherichia coli O157:H7, Salmonella typhimurium, Staphylococcus aureus, and Listeria monocytogenes indicator bacteria suspensions were diluted to 10 6 cfu / ml, add 1:100 to sterilized LB and BHI culture media cooled to about 45℃, shake well and add 20mL / plate quantitatively, cool to make bacteria-containing plates, and then culture at 37℃ for 48h. Use a vernier caliper to measure the size of the inhibition zone of YM-4-3 for different pathogens. The measurement results are shown in the following table:
[0078]
[0079] The results showed that Lactobacillus plantarum YM-4-3 had a certain inhibitory ability against four common pathogens, including Escherichia coli, Salmonella typhimurium, Staphylococcus aureus and Listeria monocytogenes. Among them, the inhibitory ability against Escherichia coli and Staphylococcus aureus was the best, followed by Salmonella typhimurium and Listeria monocytogenes.
[0080] Example 6
[0081] Metabolome analysis of fermented soymilk
[0082] The activated YM-4-3 was adjusted to a bacterial concentration and washed twice with saline, and then added to 200 mL of sterilized soy milk to a final bacterial concentration of 1*10 8 cfu / mL soymilk, and after fermentation for 48h, fermented soymilk was obtained. Samples were taken for metabolomics analysis.
[0083] The metabolites of fermented soy milk were analyzed and compared with those of soy milk before fermentation by non-targeted metabolomics, and a total of 937 positive ion mode metabolites and 452 negative ion mode metabolites were identified. Differential metabolites were screened according to the standards of VIP>1.0 and FC>1.2. In the L48.vs.L24 comparison group, 92 positive ion mode metabolites were significantly different, of which 16 metabolites were upregulated and 76 metabolites were downregulated; there were 34 negative ion mode metabolites that were significantly different, of which 12 metabolites were upregulated and 22 metabolites were downregulated. Some metabolites were intercepted for display, such as Figure 2 According to the log2FC size of the differential metabolites, the most significantly up-regulated and down-regulated metabolites were selected for display, as shown in Figure 3 shown.
[0084] Metabolomics results showed that the content of acidic amino acids in fermented soy milk was significantly higher than that in unfermented soy milk. Acidic amino acids can regulate the balance of intestinal microbiota, increase the number of beneficial bacteria, and inhibit the growth of harmful bacteria in the intestine, thereby promoting a healthy intestinal environment. In addition, acidic amino acids can also promote intestinal peristalsis and reduce the risk of constipation. In addition, active probiotics can increase lactic acid and short-chain fatty acids in the intestinal environment, further reduce the pH value of the intestinal environment, promote intestinal peristalsis, and reduce intestinal movement time to improve constipation; probiotic metabolites have an important regulatory effect on intestinal functions such as nerve conduction and intestinal motility.
[0085] Example 7
[0086] Improvement effect of soy milk fermented with Lactobacillus plantarum YM-3-4 on constipation model mice
[0087] 1. Experimental Animals
[0088] The present invention selects 48 8-week-old SPF-grade Kunming mice, all of which are male mice. The mice are purchased from Kunming Medical University and are kept in an animal room with filtered air after purchase. After all mice are adaptively fed for 3-5 days, they are randomly divided into four groups, each with 12 mice, namely: a healthy control group (I), a constipation model group (II), a probiotic fermented soy milk feeding group (Ш) and a positive drug feeding group (constipation + positive drug feeding) (IV). The animal room has a 12-hour day and night cycle, the temperature is controlled at 25±2°C, the relative humidity is maintained at 50%-70%, the room is low-noise, and the mice are allowed to eat and drink freely. The mice are fed with sterile feed treated with radiation and drinking water sterilized by high-pressure steam. During the experiment, the weight and food intake of the mice are recorded every day, and the mouse feces are collected every day.
[0089] 2. Test methods
[0090] The healthy control group (Ⅰ) and the constipation model group (Ⅱ) were gavaged with 0.2 ml of PBS every day. The positive drug feeding group was gavaged with 0.2 ml of vegetable digestion powder at the same time every day in addition to 0.2 ml of PBS every day. The probiotic fermented soy milk group was gavaged with 0.2 ml of probiotic fermented soy milk every day. In addition, the diet and drinking water were the same. After gavage for 7 days, the mice in each group were fasted but not watered for 16 hours, and the mouse defecation experiment was performed on the 9th day. After the defecation experiment was completed, the mice continued to fast for 16 hours but not watered, and the intestinal propulsion experiment was performed on the 16th day.
[0091] (1) Defecation experiment: After 7 days of oral gavage, mice were fasted but not watered for 16 h. The next day, mice in the healthy control group were given PBS, and mice in other groups were given 0.2 mL of loperamide hydrochloride solution (10 mg / kg b.w). 30 min later, mice in each group were given 0.2 mL of ink by oral gavage, and then resumed normal drinking and food intake and were kept in single cages. The timer was started at the end of ink gavage, and the time when the mouse first had black stool was recorded.
[0092] (2) Intestinal propulsion experiment: After the defecation experiment, mice were fasted but not watered for 16 h. The next day, mice in the blank control group were given PBS, and mice in other groups were given 0.2 mL of loperamide hydrochloride solution (10 mg / kg bw). After 30 min, mice in each group were gavaged with Chinese ink. After 30 min, the mice were killed, the abdominal cavity was opened, and the upper end from the pylorus to the lower end to the cecum was cut off. The total length of the small intestine was measured as the "total length of the small intestine", and the length from the pylorus to the front of the ink was the "ink propulsion length". The small intestinal propulsion rate was calculated according to the following formula.
[0093] Small intestine propulsion rate (%) = (ink propulsion length (cm)) / (total small intestine length (cm)) × 100%
[0094] The statistical results of the first black stool discharge time are shown in the following table:
[0095]
[0096] The results of the intestinal propulsion experiment are shown in the following table:
[0097]
[0098] The mouse defecation experiment showed that loperamide hydrochloride solution can effectively induce constipation. The results showed that the first fecal discharge time of the constipation model group was significantly longer than that of the blank control group, and the amount of feces was also significantly lower than that of the blank control group, indicating that the constipation model was successfully established. The first defecation time of mice gavaged with probiotic fermented soy milk for 7 days was significantly lower than that of the constipation model group, and the amount of feces was also significantly higher than that of the model group, proving that probiotic fermented soy milk can effectively improve constipation in mice. The first defecation time of mice gavaged with probiotic soy milk for 7 days was not much different from that of the positive control group, which also shows that probiotic soy milk can effectively relieve constipation in mice. After constipation was induced by loperamide hydrochloride solution, the small intestinal propulsion rate of mice in the constipation model group was significantly lower than that of the blank group. The probiotic fermented soy milk intervention group can significantly improve intestinal peristalsis and propulsion rate. The results show that probiotic fermented soy milk has a good improvement effect on constipation.
[0099] Example 8
[0100] Drug sensitivity test of Lactobacillus plantarum YM-4-3
[0101] The drug sensitivity paper agar diffusion method was used to detect the drug sensitivity of the strain: after activating YM-4-3, it was inoculated into MRS liquid culture medium at a rate of 4‰ and cultured for 24 hours. Centrifuged at 8000rpm for 5 minutes, and the bacterial precipitate was collected. The bacterial precipitate was washed twice with sterile saline, and the bacteria were adjusted to a McFarland concentration of 0.5 with sterile saline. Take 100μL of the bacterial suspension and spread it evenly on the MRS solid plate. The plate was placed in a 37℃ incubator and allowed to stand for 30 minutes. After the bacterial suspension was completely absorbed, the drug-sensitive paper was clamped with sterile tweezers and attached to the surface of the plate. Three parallel plates were set up in each group and cultured at 37℃ for 18 hours. The culture results are as follows: Figure 4 shown.
[0102] The size of the inhibition zone was measured with a vernier caliper, and the antibiotic sensitivity level of the strain was determined according to the standard SN / T1944-2016 "Determination of bacterial resistance in animals and their products - Paper diffusion method". The results of the evaluation of the antibiotic sensitivity of Lactobacillus plantarum YM-4-3 are shown in the following table:
[0103]
[0104] Note: “S”: sensitive; “I”: moderately sensitive; “R”: resistant; “--”: no inhibition zone
[0105] It can be seen that YM-4-3 is sensitive to common drugs such as ampicillin, chloramphenicol, erythromycin, gentamicin and tetracycline. It is moderately sensitive to the fluoroquinolone antibiotic ciprofloxacin. It is resistant to vancomycin and rifamycin. Overall, Lactobacillus plantarum YM-4-3 has no resistance to the five common antibiotics and is a safe strain.
[0106] Example 8
[0107] Antioxidant capacity assay
[0108] Preparation of cell-free extract of Lactobacillus plantarum YM-4-3: YM-4-3 was activated and inoculated into MRS liquid medium for cultivation. 9 cfu / mL~10 10 cfu / mL, centrifuge at 8000rpm for 5min to remove the culture medium. Collect the bacteria and resuspend the precipitate with physiological saline; use a cell disruptor at 20kHz frequency for 30min in an ice bath, and then centrifuge at 12000rpm for 5min to obtain the cell-free supernatant, which is used as the sample to be tested for antioxidant capacity.
[0109] DPPH free radical scavenging ability assay
[0110] Dissolve DPPH in anhydrous ethanol to prepare a 0.2 mM DPPH solution; add 1 mL of the test solution to 1 mL of the DPPH solution, shake well, and react in the dark for 30 minutes. Centrifuge at 12000 rpm for 2 minutes and take the supernatant; measure the OD value of the supernatant at a wavelength of 517 nm, and calculate the DPPH free radical scavenging rate:
[0111] Clearance rate / % = [1-(OD A1 -OD A2 ) / OD A0 ]×100%; among which:
[0112] A0: 1mL anhydrous ethanol + 1mL DPPH solution;
[0113] A1: 1mL test solution + 1mL DPPH solution;
[0114] A2: 1mL test solution + 1mL anhydrous ethanol.
[0115] ABTS free radical scavenging ability assay
[0116] Dissolve ABTS in anhydrous ethanol to prepare a 7mM ABTS stock solution; prepare a 5mM potassium persulfate solution at the same time, mix the two in a 1:1 volume ratio, and react in the dark for 12 hours to obtain an ABTS working solution. Dilute the ABTS working solution 20 times with PBS (pH = 7.4) before use. Take 0.5mL of the test solution and add it to 4.5mL of the diluted ABTS working solution. After shaking, react in the dark for 6 minutes, centrifuge at 12000rpm for 2 minutes, and take the supernatant; measure the OD value of the supernatant at a wavelength of 734nm, and calculate the ABTS free radical scavenging: scavenging rate / % = [1-(OD A1 -OD A2 ) / OD A0 ]×100%;
[0117] in:
[0118] A0: 0.5 mL distilled water + 4.5 mL ABTS solution;
[0119] A1: 0.5mL test solution + 4.5mL ABTS solution;
[0120] A2: 0.5 mL of test solution + 4.5 mL of anhydrous ethanol.
[0121] According to the above experimental determination, Lactobacillus plantarum YM-4-3 has an excellent DPPH free radical scavenging rate of 72.39% and an ABTS free radical scavenging rate of 65.32%, indicating that Lactobacillus plantarum YM-4-3 has the potential to prepare antioxidant products.
[0122] The embodiments of the present invention are described in detail above with reference to the accompanying drawings, but the present invention is not limited to the described embodiments. For those skilled in the art, various changes, modifications, substitutions and variations of these embodiments are made without departing from the principles and spirit of the present invention, and still fall within the scope of protection of the present invention.
Claims
1. A strain of Lactobacillus plantarum YM-4-3, characterized in that: The Lactobacillus plantarum YM-4-3 (Lactobacillus plantarum YM-4-3) was deposited in the China Center for Type Culture Collection on March 6, 2023, with a deposit number of CCTCC NO: M2023253.
2. A bacterial agent, characterized in that: It includes the plant lactobacillus YM-4-3 described in claim 1.
3. A fermentation product obtained by fermenting the plant lactobacillus YM-4-3 according to claim 1 or the bacterial agent according to claim 2.
4. Use of the plant lactobacillus YM-4-3 according to claim 1, the bacterial agent according to claim 2, or the fermentation product according to claim 3 in preparing a product for preventing or improving constipation.
5. The use according to claim 4, characterized in that: The product is food or health product.
6. Use of the plant lactobacillus YM-4-3 according to claim 1, the bacterial agent according to claim 2, or the fermentation product according to claim 3 in the preparation of antioxidant products.
7. The use according to claim 4, characterized in that: The product is food or health product.
Citation Information
Patent Citations
Lactobacillus plantarum ZJUF T34 and application thereof
CN109234182A
Lactobacillus plantarum with antioxidant and bacteriostatic functions and application thereof
CN116286454A
Lactobacillus plantarum SC75-2-2 with high oxidation resistance and application thereof
CN116716203A
Cited By
Lactobacillus plantarum capable of relaxing bowels and application of lactobacillus plantarum
CN120648609A
Probiotic composition, bean-based fermented food and application of bean-based fermented food
CN120905078A
Lactobacillus plantarum as well as derivative, composition and application thereof
CN121182723A
Phytobacterium plantarum LP-Z6 for improving functional constipation of infants and application of phytobacterium plantarum LP-Z6
CN121427738A
Lactobacillus plantarum LP-Z6 for improving functional constipation in infants and young children and its application
CN121427738B
